• 中文
    • 登錄
    • 聯系我們
    ×
    目錄產品 » Anti-Ustekinumab Antibody (5F9), mAb, Mouse
    Anti-Ustekinumab Antibody (5F9), MAb, Mouse

    ELISA binding of Anti-Ustekinumab Antibody (5F9), mAb, Mouse (GenScript, A02117-40) with Ustekinumab. While the antibody does not recognize the human IgG (data not shown).
    Coating antigen: Ustekinumab, 1 μg/ml.
    Anti-Ustekinumab Antibody (5F9), mAb, Mouse (GenScript, A02117-40) dilution start from 1,000 ng/ml.
    EC50= 30.08 ng/ml.

    Anti-Ustekinumab Antibody (5F9), MAb, Mouse

    Standard curve of Ustekinumab Sandwich ELISA. The Ustekinumab Sandwich ELISA assay is developed by using Anti-Ustekinumab Antibody (9A5), mAb, Mouse (GenScript, A02118-40) and Anti-Ustekinumab Antibody (5F9), mAb, Mouse (GenScript, A02117-40) as the capture and detection antibodies, respectively.
    In this ELISA assay, Anti-Ustekinumab Antibody (5F9), mAb, Mouse (GenScript, A02117-40) was labeled with Biotin.
    GenScript can provide customized conjugation services for this product per the customer's request.
    The sensitivity of detecting Ustekinumab is up to 0.87 ng/ml.

    Anti-Ustekinumab Antibody (5F9), mAb, Mouse

    This product is specific for Ustekinumab
    A02117
    ¥990

    聯系我們
    Specificity This product is specific for Ustekinumab
    Host Species Mouse
    Immunogen Ustekinumab
    Conjugate Unconjugated

    Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
    Application Recommended Usage
    ELISA 0.01-1 μg/ml

    Form Lyophilized
    Storage Buffer This product is lyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
    Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml.
    Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles.
    Purification Protein A affinity column
    Isotype Mouse IgG1,κ
    Clonality Monoclonal
    Clone ID 5F9
    Note GenScript can customize this product per customer's request including product size, buffer components, etc.

    • Anti-Ustekinumab Antibody (5F9), MAb, Mouse
    • Anti-Ustekinumab Antibody (5F9), MAb, Mouse

      ELISA binding of Anti-Ustekinumab Antibody (5F9), mAb, Mouse (GenScript, A02117-40) with Ustekinumab. While the antibody does not recognize the human IgG (data not shown).
      Coating antigen: Ustekinumab, 1 μg/ml.
      Anti-Ustekinumab Antibody (5F9), mAb, Mouse (GenScript, A02117-40) dilution start from 1,000 ng/ml.
      EC50= 30.08 ng/ml.

    • Anti-Ustekinumab Antibody (5F9), MAb, Mouse
    • Anti-Ustekinumab Antibody (5F9), MAb, Mouse

      Standard curve of Ustekinumab Sandwich ELISA. The Ustekinumab Sandwich ELISA assay is developed by using Anti-Ustekinumab Antibody (9A5), mAb, Mouse (GenScript, A02118-40) and Anti-Ustekinumab Antibody (5F9), mAb, Mouse (GenScript, A02117-40) as the capture and detection antibodies, respectively.
      In this ELISA assay, Anti-Ustekinumab Antibody (5F9), mAb, Mouse (GenScript, A02117-40) was labeled with Biotin.
      GenScript can provide customized conjugation services for this product per the customer's request.
      The sensitivity of detecting Ustekinumab is up to 0.87 ng/ml.


    Target Background Ustekinumab with trade name Stelara, is an FDA-approved drug to Crohn's disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis, targeting both interleukins (IL)-12 and IL-23. Ustekinumab is a fully human immunoglobulin G1 kappa mAb that binds to IL-12 and IL-23. Ustekinumab binds to the p40 subunit common to IL-12 and IL-23 and prevents their interaction with the IL-12 receptor β1 subunit of the IL-12 and IL-23 receptor complexes, thereby disrupting the proinflammatory pathway.Anti-Ustekinumab Antibody (5F9), mAb, Mouse?is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Ustekinumab.
    Synonyms Mouse monoclonal to Ustekinumab/Stelara

    For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


    国产小受呻吟cv视频在线观看